|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.40 USD | -0.22% |
|
-13.43% | -28.45% |
| 04-30 | Core Laboratories Inc., Q1 2026 Earnings Call, Apr 30, 2026 | |
| 04-30 | Earnings Flash (CLB) Core Laboratories Inc. Reports Q1 Revenue $121.8M, vs. FactSet Est of $123.0M | MT |
Company Valuation: Core Laboratories Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,033 | 939.9 | 825.1 | 812.7 | 746.4 | 526.9 | - |
| Change | - | -8.98% | -12.21% | -1.51% | -8.16% | -29.41% | - |
| Enterprise Value (EV) | 1,204 | 1,097 | 973.2 | 919.7 | 746.4 | 526.9 | 526.9 |
| Change | - | -8.87% | -11.28% | -5.5% | -18.84% | -29.41% | 0% |
| P/E | 53.1x | 48.3x | 20.5x | 26.2x | 23.6x | 24.8x | 14.1x |
| PBR | 6.47x | 5.02x | - | - | - | - | - |
| PEG | - | - | 0x | -1.1x | 7.79x | -0.8x | 0.2x |
| Capitalization / Revenue | 2.2x | 1.92x | 1.62x | 1.55x | 1.42x | 1.01x | 0.96x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.01x | 0.96x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 8.79x | 6.32x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 11.8x | 8.86x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.04 | 0.04 | 0.04 | 0.04 | - | 0.04 | 0.04 |
| Rate of return | 0.18% | 0.2% | 0.23% | 0.23% | - | 0.35% | 0.35% |
| EPS 2 | 0.42 | 0.42 | 0.86 | 0.66 | 0.68 | 0.46 | 0.81 |
| Distribution rate | 9.52% | 9.52% | 4.65% | 6.06% | - | 8.7% | 4.94% |
| Net sales 1 | 470.3 | 489.7 | 509.8 | 523.8 | 526.5 | 520.6 | 547.6 |
| EBITDA 1 | 70.81 | 61.98 | 76.96 | 80.2 | 73.34 | 59.96 | 83.36 |
| EBIT 1 | 52.29 | 44.82 | 61.18 | 65.25 | 58.7 | 44.8 | 59.49 |
| Net income 1 | 19.73 | 19.45 | 40.94 | 31.4 | 31.8 | 21.18 | 37.3 |
| Net Debt | 170.9 | 157 | 148 | 107 | - | - | - |
| Reference price 2 | 22.31 | 20.27 | 17.66 | 17.31 | 16.03 | 11.43 | 11.43 |
| Nbr of stocks (in thousands) | 46,290 | 46,371 | 46,724 | 46,950 | 46,563 | 46,097 | - |
| Announcement Date | 2/2/22 A | 2/1/23 A | 1/31/24 A | 1/29/25 A | 2/4/26 A | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 24.85x | - | - | 0.35% | 527M | ||
| 23.27x | 2.76x | 12.29x | 3.56% | 22.37B | ||
| 44.58x | 5.86x | 21.59x | 0.6% | 18.97B | ||
| 19.69x | 2.83x | 11.62x | 1.32% | 3.44B | ||
| 11.85x | - | - | 2.76% | 1.99B | ||
| -39.09x | 1.34x | 8.61x | -.--% | 1.8B | ||
| 23.27x | - | - | 2.19% | 1.68B | ||
| Average | 15.49x | 3.20x | 13.53x | 1.54% | 7.25B | |
| Weighted average by Cap. | 28.35x | 3.97x | 15.89x | 2.07% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CLB Stock
- Valuation Core Laboratories Inc.
Select your edition
All financial news and data tailored to specific country editions
















